MwanzoAZN • STO
add
AstraZeneca plc
Bei iliyotangulia
kr 1,465.00
Bei za siku
kr 1,445.00 - kr 1,464.00
Bei za mwaka
kr 1,261.00 - kr 1,799.00
Thamani ya kampuni katika soko
160.49B GBP
Wastani wa hisa zilizouzwa
elfu 419.87
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
LON
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 13.56B | 18.04% |
Matumizi ya uendeshaji wa biashara | 7.79B | 4.64% |
Mapato halisi | 1.43B | 4.00% |
Kiwango cha faida halisi | 10.53 | -11.96% |
Mapato kwa kila hisa | 1.04 | 20.23% |
EBITDA | 4.63B | 45.69% |
Asilimia ya kodi ya mapato | 21.61% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 4.93B | -3.62% |
Jumla ya mali | 104.92B | 9.20% |
Jumla ya dhima | 64.12B | 8.92% |
Jumla ya hisa | 40.80B | — |
hisa zilizosalia | 1.55B | — |
Uwiano wa bei na thamani | 55.77 | — |
Faida inayotokana na mali | 7.92% | — |
Faida inayotokana mtaji | 11.38% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 1.43B | 4.00% |
Pesa kutokana na shughuli | 3.38B | 8.64% |
Pesa kutokana na uwekezaji | -1.51B | -24.00% |
Pesa kutokana na ufadhili | -4.13B | -51.54% |
Mabadiliko halisi ya pesa taslimu | -2.24B | -163.15% |
Mtiririko huru wa pesa | 2.05B | -12.38% |
Kuhusu
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, United Kingdom. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, United Kingdom; Gothenburg, Sweden and Gaithersburg in Maryland, U.S.
AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje. Throughout the twentieth century, it grew into the largest pharmaceutical company in Sweden. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
6 Apr 1999
Makao Makuu
Tovuti
Wafanyakazi
89,900
